text:
Skip to main content
Professor of Medicine, University of MichiganDirector, Pulmonary Hypertension Program at University of MichiganAnn Arbor, Mich.Board term ending: June 2018
Dr. Vallerie McLaughlin received her bachelor's degree in Biomedical Engineering at Northwestern University, Technologic Institute, Evanston, Illinois, and her Doctor of Medicine from Northwestern University Medical School, Chicago, Illinois. Upon completion of her residency in Internal Medicine at the University of Michigan and her fellowship in cardiovascular diseases at Northwestern University, she served as Associate Director of the Center for Pulmonary Heart Disease at Rush University in Chicago. She is currently the Director of the Pulmonary Hypertension Program in the Division of Cardiovascular Medicine at the University of Michigan in Ann Arbor, Michigan. Dr. McLaughlin is also a Professor of Medicine.
Dr. McLaughlin is a fellow in the American College of Cardiology, the American College of Chest Physicians, and the American Heart Association. She is a member of the American Thoracic Society and the American College of Chest Physicians Pulmonary Hypertension Guidelines Panel. She was also the Chairperson of the American College of Cardiology/American Heart Association Clinical Expert Consensus Document on Pulmonary Hypertension and Chairperson of the Pulmonary Hypertension Breakthrough Initiative Steering Committee. She is a member of the American College of Cardiology Scientific Program Committee and has previously served as the Chairperson of the American Heart Association Women in Cardiology Committee.
Dr. McLaughlin's research focuses on pulmonary arterial hypertension and she has been the principal investigator of numerous clinical trials in this area. She is frequently an invited lecturer at national and international conferences on the topic of pulmonary hypertension. She is author of numerous peer-reviewed articles and book chapters. She is also a past Editor-in-Chief of Advances in Pulmonary Hypertension, the official journal of the Pulmonary Hypertension Association.
Roger Towle ChairStephen L. White, PhD Immediate Past-Chair Karen Fagan, MD Chair-ElectSally Maddox SecretaryTony Lahnston Treasurer
Erika Berman Rosenzweig, MDColleen Brunetti Richard Channick, MDColleen ConnorRamona DoyleLaura D'Anna, DrPH Stacey GauslingAmy KimberJessie Kohler, Esq Mitchell KoppelmanMichael McGoon, MD Vallerie McLaughlin, MD Rita Orth, RNRonald J. Oudiz, MDDiane RamirezFran RogersTraci StewartJack StibbsDoug TaylorMelisa Wilson, ARNP
Dorothy OlsonHarry Olson Jerry PatonPat PatonEd SimpsonJudy Simpson
For optimal viewing of PHAssociation.org, please use a standards-compliant browser such as Google Chrome or Firefox.
The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs. PHA does not endorse or recommend any commercial products or services.
801 Roeder Road, Ste. 1000, Silver Spring, MD 20910 Patient-to-Patient Support Line: firstname.lastname@example.com Privacy Policy Terms of Use Provide Feedback & Report Bugs
Designed by Matrix Group International, Inc.® | © 2017 Pulmonary Hypertension Association. All Rights Reserved.
The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.


text:
There are no items in your cart at this time.
Select your desired product options and we will notify you when it is back in stock.
The Naot Bjorn slip-ons will keep your feet comfortable, your style bold and your lower limbs supported no matter where you're going. Featuring handsomely black leather, these men's shoes can easily transition from outfit to outfit, as well as be worn in a diverse environments. The removable cork and latex midsole instinctively molds to your foot for enhanced lower limb protection, stability and cushioning. Additionally, if the sole loses its comfort, it's easily replaceable with a Naot Scandinavian footbed or a custom orthotic insert. Find your most confident stride with the Bjorn men's clog.
Naot Bjorn Black Leather Men's Shoe
Features include:
This Style is part of the Men's Scandinavian collection
This style has a medium fit
This Style is uses the FB02-SCANDINAVIAN replacement footbed
Sign up to receive new arrival, sale & special event info from us.
Note: we do not share your personal information with anyone. Period.
"I love my new MBT sandals and wish I could wear them 24/7. I want you to know how much I appreciate your exceptional care and patience helping me buy my first pair of MBT shoes. Without you, I'm sure I'd never have found my correct size and I'd never have fallen in love with these shoes. "
©2017 Footwear etc.. All Rights Reserved. For any questions or assistance call 1-800-720-0572.
Enter your Footwear etc Rewards email and password

subset: commoncrawl


text:
Joggers took off shirts to extinguish flames after victim reportedly doused self with gas.
A man set himself on fire Friday afternoon on the National Mall while facing the U.S. Capitol, witnesses reported.
The unidentified man was taken to the hospital with "life threatening injuries," a D.C. Fire Department spokesman toldThe Washington Post. Firefighters were called at 4:24 p.m. ET and arrived three minutes later at Seventh Street and Jefferson Drive, near the Air and Space Museum.
Witnesses told the Post and other news outlets that several joggers took off their shirts to extinguish the flames. One witness said the man thanked those who intervened.
The victim was "conscious and breathing" when firefighters arrived, a D.C. police spokeswoman told the paper. He was airlifted to MedStar Washington Hospital Center.
Katy Scheflen, who was walking through the Mall, said she saw the man empty a red container on himself and then set himself on fire, the Associated Press reported.
Nicole Didyk, who was jogging past, told the Post that one of the rescuers told her the man was facing the Capitol when he set himself alight. She was told he saluted before the fire, the Los Angeles Timesreported.
A woman walking on the Mall said the air "smelled strongly of burning flesh."
Police are trying to determine the man's motivation.
"I'm not aware of any signage or any articulation of any causes," U.S. Park Police Lt. Pamela Smith told AP.
Park Police temporarily closed an area of the mall at Seventh Street between Constitution Avenue NW and Independence Avenue SW.


text:
Located in Bedford, Bedford Heights, Oakwood, Valley View and Walton Hills, Bedford Reservation gives the appearance of a continuous forest of large trees and challenging terrain, which helped discouraged early logging operations.
The reservation offers trails and picnic areas, and includes Shawnee Hills Golf Course as one of its attractions. Flowing through Bedford Reservation is Tinker's Creek, named for a member of Moses Cleaveland's surveying party. The stream drops a dramatic 220 feet over a course of two miles and has cut a steep, walled gorge. The gorge, declared a National Natural Landmark, is a unique area with numerous tree, shrub and flower species.
Tinker's Creek Gorge Scenic Overlook on Gorge Parkway offers a spectacular vista particularly in the fall.
Reservation open
6 a.m. – 11 p.m.


text:
Well, here we are at the exact halfway point of 2011 and our Kansas City Royals have just been swept by the San Diego Padres. That is the same San Diego team that, despite three wins in a row, still sports a record in the lowest quarter of major league baseball. The sweep leaves Kansas City with the worst record in the American League and the second worst record in all of baseball behind the Houston Astros.
We are entering prime trade rumor time (I'm not sure exactly how many times I logged onto MLBTradeRumors yesterday, but it was more than enough) and you can bet that more columns will follow speculating on possible trades and potential moves. For today, however, this Royals squad has worn me out. I don't want to discuss Melky Cabrera or Chris Getz or, heaven forbid, Kyle Davies. Aaron Crow to the rotation? Joakim Soria on the block? Not today.
Instead, let's take a look past 2011 and, for the most part, past 2012. While it may not necessarily be an 'everything's coming up roses' sort of list, it is at least something other than the 2011 Kansas City Royals.
July 2nd is the start of the international signing period and the Royals appear to be in the lead on landing outfielder Elier Hernandez. A five tool 16 year old (if such a person can actually exist in the real world), Hernandez could be the best signee in the history of the Royals. He will almost certainly get the most money.
The Royals are also in on infielder Adelberto Mondesi, Raul's son. He won't turn 16 until July 27th and will have to wait for that day before signing. Dawel Lugo is another infielder who the Royals have interest in, but are not the leaders to sign. According to Baseball America, Lugo is a better prospect than Mondesi, but less likely to stick at shortstop. Thanks to PineTarPress for the likely signeed, by the way.
You didn't really expect to hear any Bubba Starling news yet, did you? Having drafted near the top of the order for basically a decade, Royals' fans now the drill: nobody talks much until about August 14th when it comes to getting top level picks signed. It doesn't make much sense for Starling to turn down millions now to play college football with the hope that you might make millions later (not to mention that Starling is not a prototypical NFL QB type), so I think a deal will get made roughly 8 minutes before the signing deadline.
At that point, you wonder where or even if, the Royals will try to get Starling into game action in 2011. They might well opt to wait until fall instructional games and it could be that we will have to wait until the rookie leagues start up in June 2012 before we actually see Bubba play real professional baseball. It is possible that Starling is such an athletic freak that he could move quickly through the system, but I would hold off on buying Starling jerseys until at least March of 2014.
There is a lot of talk about Melky Cabrera, Lorenzo Cain and even David Lough when it comes to the future of centerfield in Kansas City. As mentioned above, Starling enters into the conversation at some point down the road, but let's not forget about 2010 draftee Brett Eibner. After injuring his hand two games into his professional debut this April, Eiber is back in action with Kane County. While the slash line of .206/.265/.460 may not scream future major leaguer, he does have FIVE home runs in 17 games. Already 22 years old, Eibner could move quickly once he shakes off the rust.
Cheslor Cuthbert is probably the most recognized international signee currently in the system and he has done nothing to disappoint. As an 18 year old in A ball, the third baseman is hitting .309/.369/.473 with 4 home runs, 11 walks and just 17 strikeouts. While Kane County is years removed from Kansas City, Cuthbert could spend a full season at each succeeding minor league level and still make his debut in the majors at just age 22. It is very possible that Cuthbert could move quicker than that and arrive in Kansas City just in time to push Mike Moustakas to designated hitter as Billy Butler's contract expires.


text:
The future king is a mouth-breather
July 3, 2014 13:46:41 Posted at July 3, 2014 13:46:41 Photos:
Wenn, Chris Watt/ Getty
Wenn, Chris Watt/ Getty
A new portrait of Prince William was revealed yesterday by artist Dan Llywelyn Hall who, I'm sure, is a lovely person. But…um…
I have so many questions.
Why does he have a sunburn?
Why is he using concealer?
Why is there a creepy ass ghost lingering by his left hear?
Here's Will, will his mouth closed, today in Edinburgh with his grandparents and his aunt at the Thistle Service at St Giles Cathedral.


text:
Free Shipping!
Lowest Price Guarantee
The Reebok Premier 4 PRO Goalie Chest Protector is Reebok's top of the line professional chest protector, constructed from high quality materials throughout including synthetic leather, high grade durable nylon and mesh materials for added breathability.
Enhanced poly and foams are used throughout the chest protector providing lightweight protection. The Premier 4 PRO chest protector uses a dual shoulder cap setup using molded poly and foam offering contoured protection on the shoulder. The chest blocks utilize an anatomical design which allows the protection to contour to the body while maintaing excellent protection. Large 3/4" thick shoulder floaters rest on both sides of the chest offering very nice additional protection and the wide profile helps make the save. Added protection for your sternum comes from the floating sternum guard, able to disperse the impact energy over a larger portion of the chest blocks.
Several adjustment features have been included to ensure a snug fit with this chest protector. There are five elastic straps that secure your arm ensuring a custom and comfortable fit. This chest protector uses an two adjustable 1" elastic buckle straps to secure the fit around your midsection. Additional adjustment options have been included to the spine pad using two nylon straps allowing the goalie to adjust how the chest protector rests on the shoulders and addresses the front-to-back weight distribution. This chest protector allows for a lot of adjustability so you can customize the fit to your body.
The Reebok Premier 4 PRO chest protector offers professional level protection for goalies looking for the best Reebok's got to offer.
- Model Number: ABP4P
- Heritage: Reebok
- Level of play: (Intermediate)
- Roller: Professional
- Ice: Professional
- Construction
- Heavy Duty nylon on the majority of the chest protector
- Nylon and elastic straps
- Advanced foams and poly used for protection
- Shoulder:
- Large shoulder wings for increased net coverage
- Molded poly shoulder caps
- Chest:
- SOLIDSEAL - Vertical chest blocks
- Creates a tight arm-to-chest seal
- Chest Adjustment
- New chest design that sits higher on the body with Velcro front-to-back adjustment
- Anatomically designed chest blocks
- Sternum floater
- Stiff plastic guard padded with pressed foam
- Extended rib protection
- Wraps around protecting your lower back and rib area
- Additional lower stomach flap
- Additional abdominal protection
- Arms:
- Hinged arm floaters
- Additional flexibility and protection
- Arms are stitched onto main portion of the chest protector
- Keeps the arms from sagging
- JDP® (Joint Discharge Principal) elbow caps
- Plastic caps disperse impact away from the elbow
- Five adjustable 1" elastic straps
- Upper arm strap
- Two elbow straps
- Forearm strap
- Wrist strap
- Back:
- One-piece back construction
- Provides improved fit, mobility, and protection
- Full length back padding with plastic spine protection
- Offers excellent back and spine protection
- Weight:
- 4.85lbs (Based on a Intermediate Small/Medium)
Comments: This by far is the best chest protector I have owned. I am on the ice about 5 times a week, and it handles all shots very well. I'm facing slap shots, wristers, etc. I
have not seen one tear on this thing. It doesn't hang low on me considering I'm 5'1. Highly recommended to any goaltender.
From: Katelyn, Toms River, NJ


text:
Jaclyn Jensen, daughter of Larry and LaRae Jensen of Price, and Brett Jeffs, son of Lee and Pam Jeffs of Castle Dale, have chosen to be married in the Manti Temple on Feb. 24.
Brett served in the Japan Nagoya Mission and graduated from Snow College. Jaclyn is a licensed cosmetologist.
They will make their first home in Provo where Brett is in the electrical automation program at Utah Valley State College.
They will be honored at a reception on Saturday in Price at 300 West 500 South from 6-8 p.m.
Neil and Joyce Howard announce the marriage of their daughter, Pacee Jean to Chet Benny Allred, son of Benny and Evelyn Allred on Feb. 24.
A reception will be held in their honor that evening from 6:30-8:30 p.m. at the Price Elks Lodge, 23 East 100 North, Price. Dancing will follow.
Rebecca Nielson and Chad Norton have chosen Feb. 24 to be married.
A reception will be held in the newlyweds honor that evening from 6-8 p.m. at the Elmo LDS Church.
The parents of the bride are Kerry and Vickie Nielson.
The parents of the groom are Leonard and Michelle Norton.


text: Employment Background Checks & Identity Verification Overview Solutions Specialty Solutions Giving you the insights to make the best decision for your business First Advantage leads the industry, delivering over 16 million background screenings annually, with solutions designed to ensure your candidates have the background skills, attitudes, and aptitudes to make a positive difference in your organization, whether they are candidates, employees, contractors, or volunteers, from anywhere in the world. No matter your industry, business size, or hiring reach, we deliver precision and insight to fit your specific screening needs with these powerfully distinct advantages: Unmatched global screening expertise and coverage with 27 offices across 13 countries, and screening coverage in more than 227 countries and territories. See our full list of locations. Exclusive, "one-world" program access gives you consolidated access to worldwide background screening, drug screening, and fingerprinting services with multilingual ordering capabilities and a built-in compliance engine. Industry-leading turnaround times to accelerate your screening and selection processes and reduce costs related to hiring delays. Vast solution suite of intelligently packaged data to help you comply with industry standards and support your full hiring lifecycle to give you the precise insight you need to compete for, onboard and retain the best talent. We're here when you need us with detailed support for technology integrations, program customization and process automation, flexible options for proactive user training, and knowledgeable customer service seven days a week. Employment Solutions Overview Enterprise Advantage Demo (video) – The latest global employment screening product with greater compliance innovations. Identity – Efficiently and consistently validate the identities, immigration status and professional and educational backgrounds of applicants. Criminal records and sanctions – Quickly and effortlessly search for relevant criminal records, sex offenses and professional or financial sanctions. Fingerprinting Services – Flexible end-to-end solutions for digitally scanning fingerprints make compliance with industry-specific requirements faster and easier. Wellness, substance abuse and employee assistance – Reduce workplace-related accidents and illnesses by ensuring candidates and employees are healthy, productive, and drug free with complete program management solutions. Credentials and references – Swiftly and consistently confirm vital professional qualifications and better understand the personal character of potential employees. Scheduling – Optimize the candidate experience with easy online and phone-based tools for scheduling candidate and employee drug testing and fingerprint collections. Specialty Services Contractor, vendor & temporary staff screening Knowing your contingent workforce is just as qualified as your employees can protect the integrity of your business, even while helping to ensure the safety of your customers and team. Executive screening For top positions in your company, a thorough, far-reaching background check is needed to minimize risk and unnecessary media exposure by verifying all aspects of their credentials as well as information excluded from their resumes. Volunteer screening First Advantage offers a variety of products, services and community-based initiatives designed for non-profit organizations. Small and medium-sized business services Finding quality employees who are a good fit for your business is likely even more important than for larger businesses. You need to make sure you hire qualified people while also ensuring that your business, reputation and employees are safe. We can help. Find out how—contact First Advantage today!


text:
Charles Newton Contributor
Inducted in 2006
Naismith Memorial Basketball Hall of Fame Inductee 2000
Charles Newton contributed to the sport in the roles of player, coach, and administrator for over 50 years. He played with the 1951 University of Kentucky team that compiled a 32-2 record and won the NCAA Championship. He also coached Transylvania College, the University of Alabama and Vanderbilt University. Newton was named the SEC Coach of the Year in 1972, 1976, 1988, and 1989. In 1989, Newton returned to UK as Athletic Director. He is credited with hiring UK's first African-American men's and women's basketball coaches. In addition to playing and coaching, Newton Served on numerous NCAA Division I basketball committees, was President of USA Basketball from 1992 to 1996 and was a major influence in the selection of the original Olympic Dream Team of 1992.
Where They Are Now
Retired from Big East Conference
Where They Were
Transylvania University 1956-1968
University of Alabama 1969-1980
Vanderbilt University 1982-1989


text:
Style # 204806
Crafted from luxurious silk and sporting front utility-style pockets, this bebe button up blouse is sure to be a strong wardrobe player. Try it tucked in to pencil skirts or reach for the leather pants for a quick cocktail look.
- 100% silk.
- Center back to hem: 28" (71 cm).
- Dry clean.
- Imported.
- Model is 5'9" and is wearing a US size S.
Rated 4.5 out of 5�by 2 reviewers.
Rated 4 out of 5�by sexyT chic sheer blouse this blouse is so sexy and chic. The fit is perfect. I would have gave it 5 stars but when I received the shirt it was very wrinkled do to the packaging. I had to send the shirt to the cleaners. Other than that the blouse is perfect. January 7, 2013
Rated 5 out of 5�by locoinparadise Gorgeous! Love this blouse....so beautiful and sexy without being obvious! Goes from work to cocktails.....a little pricey but worth it! This blouse is a winner!! November 5, 2012
1-2 of 2


text:
Chapter 2
We are saved by grace through faith—The blood of Christ saves Jew and Gentile alike—The Church is built upon the foundation of apostles and prophets.
1 And you hath he quickened, who were
2 Wherein in time past ye walked according to the course of this
3 Among whom also we all had our conversation in times past in the
4 But God, who is rich in
5 Even when we were dead in sins, hath
6 And hath raised us up together, and made us sit together in heavenly places in Christ Jesus:
7 That in the ages to come he might shew the exceeding
8 For by
9 Not of works, lest any man should
10 For we are his
11 Wherefore remember, that ye being in time past Gentiles in the flesh, who are called
12 That at that time ye were without Christ, being aliens from the commonwealth of Israel, and
13 But now in Christ Jesus ye who sometimes were far off are made nigh by the blood of Christ.
14 For he is our
15 Having
16 And that he might
17 And came and preached peace to you which were afar off, and to them that were nigh.
18 For through him we both have access by one Spirit unto the Father.
19 Now therefore ye are no more
20 And are built upon the foundation of the
21 In whom all the building fitly framed together groweth unto an holy temple in the Lord:
22 In whom ye also are builded together for an habitation of God through the Spirit.


text:
Trick or Treat
UDM Law's hallowed halls were filled with superheroes, princesses, even a skunk for an evening of trick-or-treating and a Halloween party. Two student groups, Law Students with Children and Phi Alpha Delta, worked with other student groups and UDM Law's faculty and administration to offer this fun event to students' children. There were trick-or-treat stations throughout the building, and the Halloween party included games, more treats, and a costume contest. Even some of the "grown ups" got in the spirit and donned costumes. Please click here for pictures.


text:
Dave Douglas brought his ensemble Brass Ecstasy to Amherst last night to play a beautifully-programmed benefit concert in memory of his mother, Emily Douglas, who died on August 27 at the age of 78. Emily had made her home in Amherst in recent years and was an active member of the Amherst South Congregational Church, site of the concert. Brass Ecstasy, which Douglas founded a few years ago in tribute to the late trumpeter Lester Bowie's Brass Fantasy, last night featured Josh Roseman on trombone, Vincent Chancey on French horn, Marcus Rojas on tuba, and Ben Perowsky on drums.
The concert began with "Spirit Moves," a Douglas original and the title track of Brass Ecstasy's 2009 debut recording. The tune's cadence and gospel harmonies evoke both New Orleans parade music and the richly expressive trombone shout band tradition of the African American church. It set the tone for the evening's soulful reflection on Emily, a lover of the arts whom Dave credited with "encouraging" everything he's explored in his stylistically daring and wide-ranging career. He estimated that she saw him in concert well over 200 times.
Douglas arranged two of his mother's favorite hymns for the memorial, "God Be with You Till We Meet Again," and "This Is My Father's World." For the latter, he invited the congregation to sing to the accompaniment of Brass Ecstasy and organist Marilyn Brayne, South Church's music director. (I must admit to how elevating it felt to sing under Douglas's direction, and to indulge for a minute or two in the fantasy of being a member of his ensemble.)
Douglas, a perennial #1 Trumpeter in the Downbeat Critics Poll, has created an acclaimed body of compositions as well, and last night he presented a work composed during a recent Aaron Copland Residency. He lauded Copland's inherently American themes like "Appalachian Spring" and "Fanfare for the Common Man" as he introduced his composition "Safeway," a reflection on the shooting of Arizona Congresswoman Gabrielle Giffords at a supermarket near Tucson last January while he was at the Copland Center in the Hudson River Valley.
As on Brass Ecstasy's two Greenleaf Music releases, Vincent Chancey was the featured soloist on Hank Williams's "I'm So Lonesome I Could Cry," his French horn the ideal voice of the "lonesome whippoorwill" and "robin's weep." And Roseman was especially expressive on the rarely-heard John Coltrane blues, "Mr. Syms." Douglas offered another piece from the Brass Ecstasy repertoire, "Rava," his tribute to the Italian trumpeter Enrico Rava; at last year's Newport Jazz Festival, Douglas told the audience about a film clip that had recently surfaced of Rava in 1958 describing himself as "the world's greatest trumpeter." Douglas has a good-natured brassiness of his own that must surely delight in bold assertions of this kind.
Brass Ecstasy concluded with a celebratory take on "This Little Light of Mine," the gospel standard that transformed South Congregational into a veritable revival meeting last night.
Here's the NPR Music feature on Brass Ecstasy at the 2010 Newport Jazz Festival.


text:
|Posted by Terry Love on August 01, 2002 at 23:35:59:
|In response to Re: Galvanized water line
: We are considering buying a 70 year old home. Our inspector discovered that the main water line from the street to the house is galvanized (all the lines in the house have been replace with copper). He gave us the impression that it could break tomorrow (or it could last another 20 years). It seems to me that it shouldn't be much of a problem because right now the water pressure in the house is too high (100 psi). So how serious an issue is this?
|Replies to this post
|There are none.


text:
Gucci Leather Wedge Pump
Sorry, this item is sold out!
Looks like you've got more shoe shopping to do - have fun!
Looks like you've got more shoe shopping to do - have fun!
Item # dsw12prod4160234
Known best for its Italian craftsmanship and elegant style, Gucci is a worldwide legend in designer fashion. With timeless style & iconic appeal, this leather wedge pump is the perfect addition to your shoe collection.
- PLEASE NOTE: For this style, we recommend ordering a ½ size larger than normal
- Leather upper
- Round toe
- Fully lined in leather
- 3¼" wedge heel
- Leather sole
- Made in Italy
- Exclusively at DSW
- View more Women's Gucci Shoes
- Online Exclusive!
By: Romicita
Location: Miami beach
July 13, 2013
Gucci freak
"these pair of shoes are the greatest .Gucci agrees with me. I love the fit, price was unbelievable cheap !,,these are originals"
Click anywhere to close this.


text:
See also Authority; Priesthood
The ability to do something. To have power over someone or something is to have the ability to control or command that person or thing. In the scriptures, power is often connected with the power of God or the power of heaven. It is often closely related to priesthood authority, which is the permission or right to act for God.
- For this cause have I raised thee up, to show in thee my power:Ex. 9:16;
- God is my strength and power:2 Sam. 22:33;
- Withhold not good when it is in the power of thine hand to do it:Prov. 3:27;
- Truly I am full of power by the spirit of the Lord:Micah 3:8;
- All power is given unto me in heaven and in earth:Matt. 28:18;
- They were astonished at his doctrine: for his word was with power:Luke 4:32;
- Tarry ye in the city until ye be endued with power from on high:Luke 24:49;
- As many as received him, to them gave he power to become the sons of God:John 1:12; ( D&C 11:30; )
- Ye shall receive power, after that the Holy Ghost is come upon you:Acts 1:8;
- There is no power but of God:Rom. 13:1;
- You are kept by the power of God through faith unto salvation:1 Pet. 1:3–5;
- I am filled with the power of God:1 Ne. 17:48;
- It has been made manifest unto me by the power of the Holy Ghost:Jacob 7:12;
- A man may have great power given him from God:Mosiah 8:16;
- They taught with power and authority of God:Alma 17:2–3;
- Nephi did minister with power and with great authority:3 Ne. 7:15–20; ( 3 Ne. 11:19–22; )
- Although a man may have power to do mighty works, if he boasts in his own strength he must fall:D&C 3:4;
- The power to do good is in each person:D&C 58:27–28;
- In the ordinances of the Melchizedek Priesthood the power of godliness is manifest:D&C 84:19–22;
- The rights of the priesthood are inseparably connected with the powers of heaven:D&C 121:34–46;
- I will lead thee by my hand, and my power shall be over thee:Abr. 1:18;


text:
Skip to content
Key resources
Wirraka Maya Health Service Aboriginal Corporation
Port Hedland
This audiovisual seeks to raise awareness of the risk factors of diabetes among Aboriginal and Torres Strait Islander people. It states that the following factors can increase their chances of suffering from the disease:
It demonstrates how to seek medical advice on ways to manage this chronic disease from their local doctor and health worker.
Australian Indigenous HealthInfoNet abstract
Wirraka Maya Health Service Aboriginal Corporation
17 Hamilton Road
South Hedland WA 6722
Ph: (08) 9172 0400
Fax: (08) 9140 2966
Email: firstname.lastname@example.com
Report broken link


text:
To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724). E-mail: email@example.com
A Phase I, MultiCenter, Open-Label, Dose-Escalating, Safety Study of Human Cord Blood Derived, Culture Expanded, Natural Killer Cell (PNK-007) Infusion with Subcutaneous Recombinant Human IL-2 (RHIL-2) In Adults with Relapse and/or Refractory Acute...Principal Investigator: Wang, Eunice S
A Phase 1 Dose-Escalation and Cohort-Expansion Study of Intravenous CBL0137 in Subjects with Previously Treated Hematological CancersPrincipal Investigator: Bhat, Seema A
S1416, Phase II Randomized Placebo-Controlled Trial of Cisplatin with or without ABT-888 (Veliparib) in Metastatic Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast CancerPrincipal Investigator: Levine, Ellis G
Principal Investigator: Ernstoff, Marc S
A011401; Randomized Phase III Trial Evaluating The Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast CancerPrincipal Investigator: O'Connor, Tracey L
Phase 1/2 Dose-Escalation, Safety, Clinical Activity, Pharmacokinetic and Pharmacodynamic Study of the ERK1/2 Inhibitor BVD-523 in Patients with Acute Myelogenous Leukemia or Myelodysplastic SyndromesPrincipal Investigator: Wang, Eunice S
NRG-GY004: A Phase III Study Comparing Single-Agent Olaparib or the Combination of Cediranib and Olaparib to Standard Platinum-Based Chemotherapy in Women with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal CancerPrincipal Investigator: Lele, Shashikant B
(CITN-12) Phase I Study of MK-3475 (Pembrolizumab) in Patients with Human Immunodeficiency Virus (HIV) and Relapsed/Refractory or Disseminated Malignant NeoplasmPrincipal Investigator: Ernstoff, Marc S
A Phase II Study of Enzalutamide(NSC# 766085) for Patients with Androgen Receptor Positive Salivary GlandsPrincipal Investigator: Chen, Hongbin
Principal Investigator: Levine, Ellis G
Principal Investigator: Levine, Ellis G
MATCH Treatment Subprotocol Z1D: Nivolumab in Patients with Tumors with Mismatch Repair Deficiency (Excluding Colorectal Cancer)Principal Investigator: Levine, Ellis G
MATCH Treatment Subprotocol Z1B: Phase II Study of Palbociclib (PD-0332991) in Patients with Tumors with CCND1, 2, 3 Amplification and Rb Protein Expression by IHCPrincipal Investigator: Levine, Ellis G
MATCH Treatment Subprotocol Z1A: Binimetinib in Patients with Tumors (Other Than Melanoma) with NRAS MutationsPrincipal Investigator: Levine, Ellis G
A Phase I/II Study of the EGF Vaccine CIMAvax in Combination with the Anti-PD1 Nivolumab in Patients with Previously Treated Advanced NSCLCPrincipal Investigator: Dy, Grace K
Principal Investigator: Levine, Ellis G
Double-arm, Randomized Study of Botulinum Toxin Injection as a Pyloric Drainage Procedure for Minimally Invasive Esophagectomy (Phase II)Principal Investigator: Kukar, Moshim
MATCH Treatment Subprotocol W: Phase II Study of AZD4547 in Patients with Tumors with Aberrations in the FGFR PathwayPrincipal Investigator: Levine, Ellis G
(EA3132) Phase II Randomized Trial of Adjuvant Radiotherapy With or Without Cisplatin for p53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)Principal Investigator: Chen, Hongbin
Principal Investigator: Ernstoff, Marc S
A Multi-center, Open Label, Randomized Phase 2 Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell CarcinomaPrincipal Investigator: George, Saby
A Phase 3 Randomized, Double-blind, Multi-center Study of Adjuvant Nivolumab versus Placebo in Subjects with High Risk Invasive Urothelial CarcinomaPrincipal Investigator: Chatta, Gurkamal S
(EA5142) Adjuvant Nivolumab in Resected Lung Cancers (ANVIL) - A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung CancersPrincipal Investigator: Dy, Grace K
A Phase 1, Multi-Center, Open-Label Study of IMGN779 Administered Intravenously in Adult Patients with Relapsed/Refractory CD33-Positive Acute Myeloid LeukemiaPrincipal Investigator: Wang, Eunice S
A Phase I Study of Donor BPX-501 T Cell Infusion for Adults with Recurrent or Minimal Residual Disease Hematologic Malignancies Post-Allogenetic TransplantPrincipal Investigator: Chen, George L
A Phase III Study of Pembrolizumab (MK-3475) vs. Chemotherapy in Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (KEYNOTE-177)Principal Investigator: Boland, Patrick M
A Phase I/II Open-Label, Dose Escalation, Safety and Activity Study of the Antibody-Drug Conjugate CDX-014 in Advanced or Metastatic Renal Cell Carcinoma (RCC)Principal Investigator: George, Saby
A Randomized, Double-Blind Phase 3 Study of Vadastuximab Talirine (SGN-CD33A) Versus Placebo in Combination with Azacitidine or Decitabine in the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)Principal Investigator: Wang, Eunice S
(A-US-52030-328) A Phase 3, Prospective, Randomized, Double-Blind, Multi-Center, Study of the Efficacy and Safety of Lanreotide Auto/Gel Depot 120 mg Plus BSC Vs. Placebo Plus BSC for Tumor Control in Subjects with Well Differentiated, Metastatic And...Principal Investigator: Chen, Hongbin
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil) to Reduce Cancer-Related Fatigue in Patients with High Grade GliomaPrincipal Investigator: Abad, Ajay P
(COG ALTE1621) Pharmacologic Reversal of Ventricular Remodeling in Childhood Cancer Survivors at Risk for Heart Failure (PREVENT-HF): A Phase 2b Randomized Placebo-Controlled (Carvedilol) TrialPrincipal Investigator: Rokitka, Denise A
A Phase 1/2, Open-Label, Dose-Escalation/Dose-Expansion, Safety and Tolerability Study of INCB059872 in Subjects With Advanced MalignanciesPrincipal Investigator: Wang, Eunice S
(SWOG 1404) A Phase III Randomized Trial Comparing Physican/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients with High Risk Resected MelanomaPrincipal Investigator: Ernstoff, Marc S
(EA6134) A Randomized Phase III Trial of Dabrafenib + Trametinib followed by Ipilimumab + Nivolumab at Progression vs. Ipilimumab + Nivolumab followed by Dabrafenib + Trametinib at Progression in Patients With Advanced BRAFV600 Mutant MelanomaPrincipal Investigator: Ernstoff, Marc S
(NRG-CC003) Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung CancerPrincipal Investigator: Prasad, Dheerendra
Principal Investigator: Levine, Ellis G
(EAY 131-V MATCH): Phase II Study of Sunitinib in Patients with Tumors with cKIT Mutations (Excluding GIST, Renal Cell Carcinoma or Pancreatic Neuroendocrine Tumor)Principal Investigator: Levine, Ellis G
Principal Investigator: Levine, Ellis G
A Randomized, Open-Label, Active-Controlled, Phase II Study of Intravenous Anetumab Ravtansine (BAY 94-9343) or Vinorelbine in Patients with Advanced or Metastatic Malignant Pleural Mesothelioma Overexpressing Mesothelin and Progressing on First Line...Principal Investigator: Dy, Grace K
(EAY 131-T MATCH): GDC-0449 (vismodegib) in Patients with Tumors (except basal cell skin carcinoma) with Smoothened (SMO) or Patched 1 (PTCH1) MutationsPrincipal Investigator: Levine, Ellis G
EAY 131-S2 MATCH): Phase II Study of Trametinib in Patients with Tumors with GNAQ or GNA11 mutationsPrincipal Investigator: Levine, Ellis G
Principal Investigator: Chen, George L
A Phase III Randomized Open- Label Study of Single Agent Pembrolizumab Vs Physicians' Choice of Single Agent Docetaxel, Paclitaxel, or Irinotecan in Subjects with Advanced/Metastatic Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus That...Principal Investigator: Atasoy, Ajlan
Principal Investigator: Levine, Ellis G
(EAY 131-N MATCH): Phase II Study of PI3K Beta Specific Inhibitor, GSK2636771, in Patients with Tumors with PTEN Mutation or Deletion, with PTEN Expression on IHCPrincipal Investigator: Levine, Ellis G
(EAY 131-I MATCH): GDC-0032 (taselisib) in Patients with Tumors (other than breast cancer) with PIK3CA Mutation but without KRAS Mutation or PTEN LossPrincipal Investigator: Levine, Ellis G
(EAY 131-B MATCH): Phase II Study of Afatinib in Patients with Tumors with HER2 Activating MutationsPrincipal Investigator: Levine, Ellis G
(EAY 131-E MATCH): AZD9291 in Patients with Tumors Having EGFR T790M Mutations (Except Non-Small Cell Lung Cancer) or Rare Activating Mutations of EGFRPrincipal Investigator: Levine, Ellis G
(EAY 131-R MATCH): Phase II Study of Trametinib in Patients with BRAF Fusions, or With Non-V600E, Non-V600K BRAF MutationsPrincipal Investigator: Levine, Ellis G
(EAY 131-H MATCH): Phase II Study of Dabrafenib and Trametinib in Patients with Tumors with BRAF V600E or V600K Mutations (Excluding Melanoma and Thyroid Cancer)Principal Investigator: Levine, Ellis G
(EAY 131-G MATCH): Phase II Study of Crizotinib in Patients with ROS1 Translocations (Other Than Patients with Non-Small Cell Lung Cancer)Principal Investigator: Levine, Ellis G
(EAY 131-F MATCH): Crizotinib in Patients with Tumors (Other Than Adenocarcinoma of Lung or ALCL) with ALK TranslocationsPrincipal Investigator: Levine, Ellis G
A Phase III Study of Lenalidomide and Low-Dose Dexamethasone With or Without Pembrolizumab (MK3475) in Newly Diagnosed and Treatment Naive Multiple Myeloma (KEYNOTE 185)Principal Investigator: Lee, Kelvin
(EAY 131-A MATCH): Phase II Trial of Afatinib in Patients with Solid Tumors (Other Than Small Cell and Non-Small Cell Lung Cancer) or Lymphomas, That Have Activating Mutations of EGFR and Have Progressed After Standard TreatmentPrincipal Investigator: Levine, Ellis G
Phase Ib Trial of Pembrolizumab (MK-3475) in Combination with Dinaciclib (MK-7965) in Subjects with Hematologic Malignancies (KEYNOTE-155)Principal Investigator: Hernandez-Ilizaliturri, Francisco J
Principal Investigator: Levine, Ellis G
Principal Investigator: Mohler, James L
(BMT CTN Protocol 1401) Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant Followed by Lenalidomide Maintenance for Multiple Myeloma with or without Vaccinations with Dendritic Cell/Myeloma FusionsPrincipal Investigator: McCarthy, Philip L
A Phase 1a/1b Study of FPA008 in Combination with Nivolumab in Patients with Selected Advanced CancersPrincipal Investigator: Opyrchal, Mateusz
Phase 1b/2a Safety and Pharmacokinetic Study of G1T28 in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC) Receiving Etoposide and Carboplatin ChemotherapyPrincipal Investigator: Chen, Hongbin
(COG AAML1522/CC-5013-AML-002) A Phase 2, Multicenter, Single-arm, Open-label Study to Evaluate the Activity, Safety and Pharmacokinetics of Lenalidomide (Revlimid®) in Pediatric Subjects from 1 to = 18 Years of Age with Relapsed or Refractory...Principal Investigator: Twist, Clare J
A Randomized, Double-Blinded, Phase II Study of Maintenance Pembrolizumab versus Placebo after First-line Chemotherapy in Patients with Metastatic Urothelial CancerPrincipal Investigator: George, Saby
(A061402) Solitary Plasmacytoma of Bone: Randomized Phase III Trial to Evaluate Treatment with Adjuvant Systemic Treatment and Zoledronic Acid Versus Zoledronic Acid after Definite Radiation TherapyPrincipal Investigator: Lee, Kelvin
(A071102) A Phase II/III Randomized Trial of Veliparib or Placebo in Combination with Adjuvant Temozolomide in Newly Diagnosed Glioblastoma with MGMT Promoter HyperMethylationPrincipal Investigator: Abad, Ajay P
A Phase II Evaluation of Pembrolizumab in Combination with IV Bevacizumab and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerPrincipal Investigator: Zsiros, Emese
An Open-Label, Randomized Phase 3 Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Subjects with Chemotherapy-Naïve Stage IV or Recurrent Non-Small Cell Lung...Principal Investigator: Chen, Hongbin
(GOG 3005) A Phase 3 Placebo-Controlled Study of Carboplatin/Paclitaxel With or Without Concurrent and Continuation Maintenance Veliparib (PARP inhibitor) in Subjects with Previously Untreated Stages III or IV High-Grade Serous Epithelial Ovarian,...Principal Investigator: Lele, Shashikant B
A Phase I Study of Safety, Tolerability and Immunological Effects of SVN53-67/M57-KLH in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance TherapyPrincipal Investigator: Lee, Kelvin
A Phase 3, Multicenter, Open-Label, Randomized Study Comparing the Efficacy and Safety of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects with Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 MutationPrincipal Investigator: Wang, Eunice S
(EA1131) A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative Basal-Like Breast Cancer following Neoadjuvant ChemotherapyPrincipal Investigator: Levine, Ellis G
Single-Arm, Non-Inferiority Study of Omission of Intraoperative Intact Parathyroid Hormone (PTH) during Minimally Invasive Parathyroidectomy for Primary HyperparathyroidismPrincipal Investigator: Kukar, Moshim
Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry (IMPACt)Principal Investigator: Levine, Ellis G
A Randomized, Open-label Phase 2 Study of Nanoliposomal Irinotecan (nal-IRI)-containing Regimens versus nab-Paclitaxel plus Gemcitabine in Patients with Previously Untreated, Metastatic Pancreatic AdenocarcinomaPrincipal Investigator: Boland, Patrick M
(COG APEC14B1) The Project: Everychild Protocol: A Registry, Eligibility Screening, Biology and Outcome StudyPrincipal Investigator: Bambach, Barbara J
Principal Investigator: Boland, Patrick M
PALLAS: PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib with Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor...Principal Investigator: Levine, Ellis G
(12-100) Phase I/II Trial of Pre-Operative Image Guided Intensity Modulated Proton Radiation Therapy (IMPT) or Photon (IMRT) with Simutaneously Integrated Boost to the High Risk Margin for Retroperitoneal SarcomasPrincipal Investigator: Salerno, Kilian E
(A031102) A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) with High-Dose Chemotherapy Using Mobilizing Pacilitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide ...Principal Investigator: Levine, Ellis G
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast CancerPrincipal Investigator: Levine, Ellis G
A Randomized, Single-Blind, Multicenter Phase 2 Study to Evaluate the Activity of 2 Dose Levels of Imetelstat in Subjects with Intermediate-2 or High-Risk Myelofibrosis (MF) Relapse/Refractory to Janus Kinase (JAK) InhibitorPrincipal Investigator: Wang, Eunice S
(S1314) A Randomized Phase II Study Of Co-Expression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder CancerPrincipal Investigator: Levine, Ellis G
A Dose Regimen-Finding Study to Evaluate the Safety, Tolerability, Maximum Tolerated Dose, Pharmacokinetics, and Activity of Oraxol in Subjects with Advanced MalignanciesPrincipal Investigator: Boland, Patrick M
Principal Investigator: Mahoney, Martin C
(ACCL1333/CV185-155) A Phase III Randomized, Open Label, Multi-center Study of the Safety and Efficacy of Apixaban for Thromboembolism Prevention versus No Systemic Anticoagulant Prophylaxis during Induction Chemotherapy in Children with Newly...Principal Investigator: Bambach, Barbara J
A Phase II Study of Blinatumomab (NSC-765986) and POMP (Prednisone, Vincristine, Methotrexate, 6 Mercaptopurine) for Patients >/= 65 Years of Age with Newly Diagnosed Philadelphia-Chromosome Negative (Ph-) Acute Lymphoblastic Leukemia (ALL) and of...Principal Investigator: Wang, Eunice S
(2215-CL-0301) A Phase 3 Open-Label, Multicenter, Randomized Study of ASP2215 Versus Salvage Chemotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with FLT3 MutationPrincipal Investigator: Wang, Eunice S
(COG AAML1331) A Phase III Study For Patients with Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic AcidPrincipal Investigator: Bambach, Barbara J
A Phase 1b/2, Open-label, Dose Escalation Study of Entinostat in Combination with Pembrolizumab in Patients with Non-small Cell Lung Cancer, with Expansion Cohorts in Patients with Non-small Cell Lung Cancer and MelanomaPrincipal Investigator: Opyrchal, Mateusz
(RU0214071) Regorafenib Dose Optimization Study (ReDOS); A Phase II Randomized Study of Lower Dose Regorafenib Compared to Standard Dose Regorafenib in Patients with Refractory Metastatic Colorectal Cancer (mCRC)Principal Investigator: Boland, Patrick M
(MM-141-07-0202) A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of MM-141 Plus Nab-Paclitaxel and Gemcitabine Versus Nab-Paclitaxel and Gemcitabine in Front-Line Metastatic Pancreatic Cancer (CARRIE)Principal Investigator: Boland, Patrick M
(COG AALL1331) Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND# 117467, NSC# 765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)Principal Investigator: Bambach, Barbara J
Gemtuzumab ozogamicin (MYLOTARG) expanded access protocol for treatment of patients in the United States with relapsed/ refractory acute myelogenous leukemia who may benefit from treatment and have no access to other comparable/alternative therapyPrincipal Investigator: Wang, Eunice S
A Phase II, Multicenter, Study of Oral cMET Inhibitor INC280 in Adult Patients with EGFR Wild-Type (wt), Advanced Non-Small Cell Lung Cancer (NSCLC)Principal Investigator: Chen, Hongbin
GOG 0286B) A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo As Initial Therapy For Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial CancerPrincipal Investigator: Lele, Shashikant B
(ASTX727-01) A Phase 1-2 Pharmacokinetic Guided Dose-Escalation and Dose-Confirmation Study of ASTX727, a Combination of the Oral Cytidine Deaminase Inhibitor (CDAi) E7727 with Oral Decitabine in Subjects with Myelodysplastic Syndromes (MDS)Principal Investigator: Griffiths, Elizabeth A
(BMT CTN Protocol 0702) Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients Who Have Enrolled on BMT CTN 0702Principal Investigator: McCarthy, Philip L
(COG ANBL1232) Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk NeuroblastomaPrincipal Investigator: Higman, Meghan
(COG AHOD1331) A Randomized Phase III Study of Brentuximab Vedotin (IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and AdolescentPrincipal Investigator: Higman, Meghan
(STML-401-0214) A Phase 1/2 Study of SL-401 as Consolidation Therapy for Adult Patients with Adverse Risk Acute Myeloid Leukemia in First CR, and/or Evidence of Minimal Residual Disease (MRD) in First CRPrincipal Investigator: Wang, Eunice S
Principal Investigator: Wang, Eunice S
A Phase II Study of the Safety and Efficacy of SVN53-67/M57-KLH (SurVaxM) in Survivin-Positive Newly Diagnosed GlioblastomaPrincipal Investigator: Fenstermaker, Robert A
(PBMTC 13-TLEC) Natural History and Biology of Long-Term Effects Following Hematopoietic Cell Transplant for Childhood Hematologic MalignanciesPrincipal Investigator: Bambach, Barbara J
(S1400) A Biomarker-Driven Master Protocol for Previously treated Squamous Cell Lung Cancer (Lung-Map)Principal Investigator: Chen, Hongbin
(ARO-006) A Safety and Tolerability Trial of Crenolanib and Chemotherapy with Cytarabine and Anthracyclines in Patients with Newly Diagnosed Acute Myeloid Leukemia with FLT3 Activating MutationsPrincipal Investigator: Wang, Eunice S
A Phase 1B Dose-Escalation and Phase 2A Study of TRC105 in Combination with Pazopanib in Patients with Advanced Soft Tissue SarcomaPrincipal Investigator: Grand'Maison, Anne C
Principal Investigator: Iyer, Renuka V
Phase II Randomized, Double-Blind, Placebo-Controlled Study Evaluating Nintedanib Versus Placebo as Prophylaxis against Radiation Pneumonitis in Patients with Unresectable NSCLC Undergoing Chemoradiation TherapyPrincipal Investigator: Dy, Grace K
Principal Investigator: Boland, Patrick M
Analysis of Analgesia Regimens during Concurrent Chemoradiation for Head and Neck Cancer: A Pilot StudyPrincipal Investigator: Singh, Anurag K
(C31001) A Phase 1b/2 Study of Safety and Efficacy of MLN0128 (Dual TORC1/2 Inhibitor) in Combination With Exemestane or Fulvestrant Therapy in Postmenopausal Women With ER+/HER2- Advanced or Metastatic Breast Cancer That Has Progressed on Treatment...Principal Investigator: Opyrchal, Mateusz
(E4512 )A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion ProteinPrincipal Investigator: Chen, Hongbin
(A081105) Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)Principal Investigator: Dy, Grace K
Principal Investigator: Dy, Grace K
(MPD-RC 109) Combination Therapy of Ruxolitinib and Decitabine in Patients with Myeloproliferative Neoplasms in Accelerated and Blast Phase DiseasePrincipal Investigator: Wang, Eunice S
(MPD-RC 107) Correlative Biomarker Study for MPD-RC Treatment Studies in the Philadelphia Chromosome Negative Myeloproliferative Neoplasms (MPN)Principal Investigator: Wang, Eunice S
Principal Investigator: Rokitka, Denise A
(NRG/COG ARST1321) Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754, IND# 118613)Principal Investigator: Salerno, Kilian E
(BMT CTN 1102) A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Intermediate-2 and High Risk Myelodysplastic...Principal Investigator: McCarthy, Philip L
Principal Investigator: Opyrchal, Mateusz
(COG AALL1231) A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphobalstic Lymphoma (T-LLy)Principal Investigator: Bambach, Barbara J
(E2112) A Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Placebo in Patients with Hormone Receptor-Positive Advanced Breast CancerPrincipal Investigator: Levine, Ellis G
Principal Investigator: Singh, Anurag K
(E1910) A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in AdultsPrincipal Investigator: Wang, Eunice S
(AC220-007) A Phase 3 Open-Label Randomized Study of Quizartinib (AC220) Monotherapy Versus Salvage Chemotherapy in Subjects with FLT3-ITD Positive Acute Myeloid Leukemia (AML) Refractory to or Relapsed After First-Line Treatment With or Without...Principal Investigator: Wang, Eunice S
A Dose-Regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects with Advanced MalignanciesPrincipal Investigator: Boland, Patrick M
(UPCC 14153) A Randomized Phase II Trial of Radical Pleurectomy and Post-Operative Chemotherapy With or Without Intraoperative Porfimer Sodium-Mediated Photodynamic Therapy for Patients with Epithelioid Malignant Pleural MesotheliomaPrincipal Investigator: Yendamuri, Sai S
A Phase I Study of Ceritinib (LDK378), a Novel ALK Inhibitor, in Combination with Gemcitabine-Based Chemotherapy in Patients with Advanced Solid TumorsPrincipal Investigator: Iyer, Renuka V
(BP-HM-001) A Phase 1-2 Dose Escalation Study Evaluating Safety and Feasibility of BPX-501 T Cells after Partially Mismatched, Related T Cell-Depleted HSCTPrincipal Investigator: Chen, George L
(BAY 1129980/16044) An Open-Label Phase I Dose-Escalation Study to Evaluate the Safety, Tolerability, Maximum Tolerated Dose, Pharmacokinetics, and Pharmacodynamics of the Anti-C4.4a Antibody Drug Conjugate BAY 1129980 in Subjects With Advanced Solid...Principal Investigator: Opyrchal, Mateusz
(KX02-01-13) A Phase 1 Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KX2-361 in Subjects with Advanced Malignancies that are Refractory to Conventional TherapiesPrincipal Investigator: Opyrchal, Mateusz
Principal Investigator: Schwaab, Thomas
(BMT CTN 1204) Reduced-Intensity Conditioning for Children and Adults with Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (RICHI)Principal Investigator: Bambach, Barbara J
(A011202) A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 NI) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant ChemotherapyPrincipal Investigator: Levine, Ellis G
A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 232 in Adult Subjects With Relapsed/Refractory Acute Myeloid LeukemiaPrincipal Investigator: Wang, Eunice S
(Alliance A011106) ALTernate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer NeoAdjuvant TrEatment (ALTERNATE) in Postmenopausal Women: A Phase III StudyPrincipal Investigator: Levine, Ellis G
A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of AGS15E Given as Monotherapy in Subjects with Metastatic Urothelial CancerPrincipal Investigator: George, Saby
(COG ALTE11C2) Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-Related CardiomyopathyPrincipal Investigator: Rokitka, Denise A
Reduced Burden of Oncologic Therapy in Advanced B-cell Lymphoma (REBOOT ABLY) in Children, Adolescents and Young Adults with CD20+ Mature B-Cell LymphomaPrincipal Investigator: Barth, Matthew J
(GOG 274) A Phase III Trial of Adjuvant Chemotherapy as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation alone: The OUTBACK trialPrincipal Investigator: Frederick, Peter
Phase I/II Study of Carfilzomib plus Rituximab plus Ifosfamide plus Carboplatin plus Etoposide (C-R-ICE) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)Principal Investigator: Hernandez-Ilizaliturri, Francisco J
N1048 PROSPECT**) A Phase II/III Trial of Neoadjuvant FOLFOX with Selective Use of Combined Modality Chemoradiaiton Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with...Principal Investigator: Nurkin, Steven J
Principal Investigator: Iyer, Renuka V
(SWOG S1216) A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Hormone Sensitive Prostate CancerPrincipal Investigator: Levine, Ellis G
A Phase I/IIa, Open Label, Clinical Trial Evaluating the Safety and Efficacy of Autologous T Cells Expressing Enhanced TCRs Specific for NY-ESO-1/LAGE-1 in Patients with Recurrent or Treatment Refractory Ovarian CancerPrincipal Investigator: Odunsi, Adekunle O
A Phase II Study of Single Agent Topoisomerase-I Inhibitor Polymer Conjugate, Etirinotecan Pegol (NKTR-102), in Patients with Relapsed Small Cell Lung CancerPrincipal Investigator: Chen, Hongbin
(COG ANBL1221) A Phase II Randomized Trial of Irinotecan/Temozolomide with Temsirolimus (NSC# 683864, IND# 61010) or Chimeric 14.18 Antibody (ch14.18) (NSC# 623408, IND# 4308) in Children with Refractory, Relapsed or Progressive NeuroblastomaPrincipal Investigator: Twist, Clare J
A Phase I Study of Surgery Plus Intraoperative Photodynamic Therapy (PDT) with Temoporfin in Patients with Resectable Primary Non-Small Cell Lung Cancer (NSCLC) with Ipsilateral Thoracic Nodal (N1 or N2) or T3/T4 DiseasePrincipal Investigator: Nwogu, Chukwumere E
Principal Investigator: Mahoney, Martin C
Principal Investigator: O'Connor, Tracey L
Pilot: Impact of High-Dose, Single Fraction Radiation on Immunogenicity of Sipuleucel-T in Metastatic Castration Recurrent Prostate Cancer PatientsPrincipal Investigator: Schwaab, Thomas
A Phase I Trial of a Recombinant Human hsp110-gp100 Chaperone Complex Vaccine for Advanced Stage IIIB/C or IV MelanomaPrincipal Investigator: Kane, John M
Impact of Carbonyl Reductase 3 Genotype Status on Echocardiographic Measurements of Cardiomyopathy in Breast Cancer Patients Treated with AnthracyclinesPrincipal Investigator: O'Connor, Tracey L
Principal Investigator: Young, Jessica S
(COG AAML1031) A Phase 3 Randomized Trial for Patients with de novo AML Using Bortezomib and Sorafenib (IND#114480; NSC#681239, NSC#724772) for Patients with High Allelic Ratio FLT3/ITDPrincipal Investigator: Beaupin, Lynda K
Influence of Advertising Claim Presentation on Beliefs and Affective Associations Related to Tobacco ProductsPrincipal Investigator: O'Connor, Richard J
A Phase I/ II Trial of Pazopanib Alternating with Bevacizumab in Treatment-Naive Metastatic Clear Cell Renal Cell Carcinoma PatientsPrincipal Investigator: George, Saby
Principal Investigator: Griffiths, Elizabeth A
COG AALL1131, A Phase III Randomized Trial for Newly Diagnosed High Risk BLymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (IND#73789, NSC#732517) in Patients with Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive MutationsPrincipal Investigator: Bambach, Barbara J
A Randomized Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib and Dexamethasone (RVD) to High-Dose Treatment with Peripheral Stem Cell Transplant in the Initial Management of Myeloma in Patients up...Principal Investigator: Torka, Pallawi
Principal Investigator: Barth, Matthew J
A Pilot Study Evaluating NFAT, NFkB and, ERK 1/2 Nuclear Translocation as a Predictive Marker for Acute Graft-versus-Host DiseasePrincipal Investigator: Chen, George L
(CIBMTR 10-CBA) A Multicenter Access and Distribution Protocol for Unlicensed Cryopreseved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other IndicationsPrincipal Investigator: McCarthy, Philip L
(COG AAML08B1) Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome (DS)Principal Investigator: Higman, Meghan
Ofatumumab (O) in Combination With Chemotherapy: Hyper-Fractionated Cyclophosphamide, Doxorubicin, Vincristine and Dexamethasone (O-HyperCVAD) Alternating With Ofatumumab High-Dose Cytarabine and Methotrexate (O-MA) for Patients With Newly Diagnosed...Principal Investigator: Hernandez-Ilizaliturri, Francisco J
Correlation of Deuterated Phenanthrene Metabolism with Bronchoepitheial Dysplasia and Metaplasia in Current and Former Smokers at High Risk for Lung CancerPrincipal Investigator: Dhillon, Samjot
Evaluation of Pre-Operative Nutritional Risk as a Predictor of Post-Operative Outcome in Patients Undergoing Robot-Assisted Radical CystectomyPrincipal Investigator: Guru, Khurshid
Principal Investigator: Rokitka, Denise A
Mediators of inflammation and injury in patients receiving cancer therapy or allogeneic hematopoietic stem cell transplantationPrincipal Investigator: Segal, Brahm
Principal Investigator: Singh, Anurag K
(COG ACNS0831) Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 YearsPrincipal Investigator: Twist, Clare J
(COG AALL0932) Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy)Principal Investigator: Bambach, Barbara J
Principal Investigator: Twist, Clare J
Principal Investigator: Rokitka, Denise A
Principal Investigator: Hong, Chi-Chen
(COG AALL05B1) A Children's Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research SpecimensPrincipal Investigator: Twist, Clare J
Principal Investigator: Hyland, Andrew J
Principal Investigator: Dhillon, Samjot
Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation with Unrelated Donors (NMDP IRB 1996-005; IRB-1999-0021)Principal Investigator: McCarthy, Philip L
Principal Investigator: Moysich, Kirsten B
Collection of Blood from Healthy Donors and Patients with Non-Hodgkin's Lymphoma to Study the Immunological Activity of Peripheral Blood Mononuclear Cells (PBMC) and Human SerumPrincipal Investigator: Hernandez-Ilizaliturri, Francisco J
Principal Investigator: Odunsi, Adekunle O
Principal Investigator: Dhillon, Samjot
Principal Investigator: Bansal Travers, Maansi
Principal Investigator: Rokitka, Denise A
Genetic Signature for Progression of Barrett's Esophagus to Esophageal Adenocarcinoma. A Pilot StudyPrincipal Investigator: Bain, Andrew J
Principal Investigator: Guru, Khurshid
Assessment of Tumor Cell Viability and Various Biomarkers from De-Identified Bladder Washing Samples Obtained From Patients with Bladder CarcinomaPrincipal Investigator: Guru, Khurshid
Principal Investigator: Hydeman, Jennifer A
Principal Investigator: Rokitka, Denise A
Principal Investigator: Voian, Nicoleta C
Intensity Modulated Radiation Therapy for Anal Cancer: Dosimetric Comparison, Acute Toxicity Profile, and Quality of Life AssessmentPrincipal Investigator: Mattson, David
(CALGB 140503) A Phase III Randomized Trial of Lobectomy Versus Sublobar Resection for Small (< 2 cm) Peripheral Non-Small Cell Lung CancerPrincipal Investigator: Nwogu, Chukwumere E
(COG ACNS0332) Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET PatientsPrincipal Investigator: Fitzpatrick, Lorna
Randomized Placebo-Controlled, Double-Blind Study Of Cholecalciferol Replacement in Patients on Expectant Management for Localized Prostate CancerPrincipal Investigator: Mohler, James L


text:
|Posted by Terry Love on March 22, 2004 at 19:35:19:
|In response to Re: Toto Ultimate vs Ultramax Toilets
: I am in the market for a two new low-flow toilets to replace two 30+ year old toilets. I was thinking of buying the Toto Ultimate toilet. Instead, my remodeling contractor recommended the more expensive Ultramax model because the Ultimate models have been troublesome, and that the factory may discontinue the Ultimate model. Question 1: Can you verify if the Ultimate models have been troublesome? Question 2: Any chance the Ultimate will be discontinued?
|Replies to this post


text:
Watch, Do, Teach
by gwilson on Jun.07, 2012, under Uncategorized
One of the hallmarks of medical education is the concept of "watch, do, teach" – watch a procedure, do the procedure, teach the procedure – as a way to grow knowledge and skill in future doctors. That same approach was used this week as Charlie Troxel from Li-Cor in Nebraska visited the BIMS labs to help McMurry faculty improve their skills with their DNA sequencer. McMurry's sequencer has been in service since 2008, but changes in personnel and projects necessitated some training upgrades. McMurry faculty used PCR to amplify their target DNA and loaded the sequencer on Wednesday afternoon. Fourteen hours later, the sequencing was done and teacher and students reconvened in the BIMS lab to observe the results. Several software packages allowed the participants to evaluate the confidence of each base sequenced and provided ways to align sequences to test their consistency. Pointers were given on how best to proceed with the plant samples Banks will analyze for Dr. Anna this summer as a part of a project to study genetic drift between specimens of a species collected in Old World and New World ecosystems. The Li-Cor 4300 will get quite a workout between now and the end of the year.
That explains the "Watch" and "Do" activities. The "Teach" component comes this fall as Banks puts the instrument to work teaching her Molecular Cell Biology Lab students how to do sequencing and analysis. Nice.


text:
Scouts' '87 time capsule: Scrunchies, fan mag, empty box of cookies
BREA – Nobody could remember what was inside the box. The Girl Scouts who made it joked at the time that their parents would be in wheelchairs and their cars would be zooming through the air before it ever saw the light of day.
But there it was Sunday, 25 years after the girls lowered it into the ground, a steel box about the size of a cooler, the white paint peeling and flecked orange with rust: a time capsule from 1987.
Maybe there's a Twinkie inside, former troop leader Kathie Cademartori suggested.
The girls of Troop 272 buried the time capsule in honor of the 75th anniversary of the Girl Scouts, sealing inside mementos of middle-school life in 1987. They left their instructions in the form of a bronze plaque: "To be opened on the 100th anniversary."
On Sunday, the husband of one of those former troop members needed a hammer, a crowbar and an hour to break the box open. A small crowd gathered in the Brea Lions Scout House – current Girl Scouts, parents and a few former troop members who were as curious as anyone to see what they had left behind all those years ago.
Carrie Rebay, now 38, a former troop member and Cademartori's daughter, pulled on gloves and reached inside. The first souvenir from the past: a golden birthday balloon with "Happy 100th" written by the girls of 1987 to the girls of 2012.
And then, of course, a green box of Girl Scouts thin mints. Empty.
There were ashes from a campfire, a banana hair clip, scrunchies, fake nails. When Rebay dug out a survival kit of matches housed in a plastic film container, she had to pause to tell the younger kids what film was.
And then came a magazine, 50 Star Pinups. The girls giggled when they flipped open a page to Charlie Sheen. "Oh my goodness!" one exclaimed when she turned the page to an image of teased and feathered hair. "That's Bon Jovi?"
Near the bottom of the box was a blue binder, a scrapbook the girls had made of life in 1987. There was an entire page devoted to "watches" and another to hair. One page showed magazine cutouts of "Women in the News": Mother Teresa, Oprah, Princess Diana.
The girls had also included a receipt from McDonald's, showing that a hamburger in 1987 cost 65 cents.
"Twenty-five years, it's so far away when you're that age," said Danielle Wilson, now 35, who still lives in Brea. "I thought it was going to be like the Jetsons. ... But we're still here, still around."
Brea Girl Scouts are putting together another time capsule, to be opened in 2037. And there has been talk of including a Twinkie this time.
Most Popular
- 12-foot shark spotted off Bolsa Chica; access to ocean closed, but beach stays open
- J.C. Penney to cut 6,000 workers, move Buena Park distribution center to Inland Empire, c
- $45 million donation to Chapman makes Fowler couple the school's largest donors at $100 m
- 13-year-old boy in scuffle with off-duty L.A. cop in Anaheim free for now
- Mission Viejo massage therapist arrested, accused in sex assault on client
User Agreement
Comments are encouraged, but you must follow our Privacy Policy Policy & Terms of Use
Keep it civil and stay on topic. No profanity, vulgarity, racial slurs or personal attacks. People who harass others or joke about tragedies will be blocked. By posting your comment, you agree to allow Orange County Register Communications, Inc. the right to republish your name and comment in additional Register publications without any notification or payment.


text:
Channel | updated June 30, 2015
Over the years, MIT students have created an array of clubs, workshops and competitions to foster entrepreneurship and help those who aim to start businesses. Increasingly, though, entrepreneurship is not just an extracurricular activity but — in many cases — an integral part of students' academic work. Read more


text:
Strike King Tour Grade Rage Blade Swim Jig
A new take on the bladed swim jig, the Strike King Tour Grade Rage Blade Swim Jig features a unique blade and head design. Instead of having the head molded onto the hook like most swim jigs and jigs in general, the weighted head is actually molded onto the blade. Field testing has shown this design greatly increases hook up percentages by giving the blade more movement to get out of the way of the hook when a fish strikes the lure. It also helps decrease snags as well thanks to the increased movement of the blade, and still delivers the classic bladed swim jig vibration that bass can't resist. The Perfect Skirt and twin tail trailers also combine to provide additional lifelike action, and a custom Gamakatsu hook is sticky sharp and ultra strong to keep fish buttoned down. If you like fishing bladed swim jigs, give the new Strike King Tour Grade Rage Blade Swim Jig a try. The results speak for themselves.
8 Colors
More From Strike King Jigs
Customer Reviews
Comments: Just won a tournament on this bait and also had a 6.61lb big fish for the kicker. First, all of the comments about not keeping it down in the water column can be controlled by your trailer. It's a great bait for open water and around docks. The one downside to the bait is that is does not go through vegetation very well as it hinders the action of the unique head, but at that point, I would switch to the swim jig if it's getting hung up that much anyway. Rock on!
From: Dan: Spokane, WA 8/22/16
Comments: This bait deflects off rip rap & rock exceedingly well. It is not a bait to burn to the boat. But when the fish are on a square bill & they turn off (or if you're getting back seated by a squarebill), grind this over the junk. Get rid of that hunk of useless trailer they provide, and run a small swimbait. Or better yet, a Missile Craw!
From: Chris: Long Beach, CA 10/20/15
Comments: Ill stick to the chatterbait elite baits.You can burn them and they stay under the surface. I bought 3 when they first came out and gave them away.
From: Joe: Rough Hill, CO 8/25/15
Comments: I have the 3/8. It looks good in the water but as others have said it won't stay down no matter what i do. Also as others said the snap pictured is inaccurate (maybe they fixed it) the snap it comes with is very cheap. Other than that it's good if you're fishing near the surface.
From: Adam: Long Island 4/23/15
Comments: This bait is killing the fish during prespawn in any shas color. Any color of water .. And big fish
From: Jay: VA 3/30/15
Comments: I wish there was an honest review I would have never bought 4 of them. I'm not sure if its a design flaw but every other cast the swivel part flips over itself and lock up. I use a bunch of Strike King stuff but these are terrible sorry.
From: Dale: Gallatin, TN 3/21/15
Comments: Don't get me wrong I love the Z-man chatterbaits but this Strike King RageBlade is killer the sexy shad color is awesome just wish they weren't $6 so you could buy more if the skirt falls off you can put a Zoom swimmin fluke in the white ice color on there and they seem to hit the mess out of it in the spring
From: Austin: Huntsville, AL 3/11/15
Comments: The Rage Blade is a machine when it comes to catching large bass. I like the 3/8 Black/Blue combination in muddy water and the 3/8 Bluegill or Green Pumpkin in clear water. Add a minnow to the hook and you have one awesome presentation that produces big fish. My biggest so far 6lb 14oz. I would recommend buying 3 or more of your color choice because if you throw these where the big ones are you are going to lose some because they snag on branches easily.
From: Yakenstein: Hickory, NC 3/9/15
Comments: This thing in a 1/2oz bluegill absolutely rocks! I've never done well on chatterbaits outside of a pond but each outing I've boated nice fish on this. Tailedit with a Yamo double tail grub and game on. Come over rock and brush better than any others I've thrown
From: Brian: York, PA 7/7/14
Comments: On my third cast of the day I caught an 8 pounder on this, which is my personal best! would recommend 1/2oz because I have the 3/8oz and it tends to not stay down.
From: Thomas: Haymarket, VA 6/30/14
Comments: I have recently started fishing with bladed jigs. I bought this after I lost a chatterbait, and I am pleased. Great action, comes through cover great with the new weighted blade design. Mine did not come with the same snap as pictured, but I have not had a problem with it so far. I have the 3/8oz and would recommend the 1/2 because the 3/8oz will not stay down even when reeled slow. Overall another great lure from strike king.
From: J.C.: USA 5/22/14
Comments: Holy cow...caught a couple of 5 pounders today...awesome considering that im in cheyenne wyoming where no bass is suppose to be...paired with Gary Yamamoto kreature...killer combo...Highly recommend...
From: Danilo: Cheyenne, WY 5/4/14
Comments: After the classic buzz on Chatterbaits I tried several chatterbait style lures out and this is by far the best. New version has an improved line tie so that is no longer and issue. Quality Gamakatsu hook. This thing is awesome for shallow grass lakes in the spring and comes through grass and pads like a beast. Pull off the skirt and add a lake fork magic shad or boot tail magic shad for a set up big bass have never seen before. Highly recommend.
From: AJ: MO 3/23/14
Comments: LEGIT. I was getting bites the guy throwing a Chatterbait wasn't.
From: Jay6: USA 3/21/14
Comments: Comes through all cover much better than other bladed swim jigs. Hook up ratio is also better.
From: Unknown: USA 3/17/14
Comments: I bought the 3/8 ounce and i couldnt get it to run no more than 3-5ft max on a very slow retrieve. Junk in my book...
From: Chris: Burlington 3/3/14
Comments: Definitely a different type of bladed swim bait. This bait comes through all types of cover MUCH better than traditional "Chatterbait-style" lures. Wicked vibration combined with confidence in throwing it in all types of cover makes this a winner, and as long as the line passes through both small loops of the line connector, it is a tremendous improvement on the old duolock snap that comes on all bladed swim baits. I tie directly with 50-65 lb. braid and have caught numerous big bass and striped bass with no distortion of the connector under heavy strain. It would be difficult to resort back to the old style of bladed swim jig after using this product.
From: Thomas: Lake Wylie, SC 2/27/14
Comments: The snap that comes with this lure is definitely in need of an upgrade. I had to change one out because the eyes would not line up. The snap that comes with it is not the one in the picture. A whole lot flimsier. I ended up changing them all out. Hard to believe SK would put such cheap hardware on a lure.
From: Mike: Central TX
Comments: definitely change the swivel out, but its a goood idea. Swivel broke in testing on a 8lb dumbell.


text:
Jellypop Aurelia Platform Sandal
Sorry, this item is sold out!
Looks like you've got more shoe shopping to do - have fun!
Looks like you've got more shoe shopping to do - have fun!
Item # 274063
Add some gorgeous glam to your next night out with the Aurelia platform sandal. This sensational slingback from Jellypop will have all eyes on you.
- Metallic faux leather or satin upper
- Pleated details
- Singback strap with adjustable buckle
- ¾" platform, 4" covered heel
- Synthetic sole
- Imported
By: YBBIL
Location: FL
August 06, 2013
Silver linings
"Bought these for a wedding, got tons of compliments. Love them!"
By: Angela143
Location: Minneapolis mn
July 18, 2013
Very comfortable Shoes:
"I bought this shoes at the Store in Silver Color. When i try it on at the Store, I can already tell that its comfy and super cute. I wear size 7 but i have to buy 7 1/2. I wear it at work and got a lot of Compliments, wear it all day and walk through it without any problem. That is how comfy this shoes are. I wish they have a different Colors. Love it!"
By: ShoeLover517
June 18, 2013
By: MissChurchill
Location: Louisville, Kentucky
June 12, 2013
Wedding Shoe
"Ordered these for a wedding and need to exchange for a bigger size. They run slightly too small for me. I suggest getting the next half size up. Otherwise, will work great for the wedding. Very comfortable and stylish so I will gets lots of wear out of them."
Click anywhere to close this.


text:
Good Morning 39.gif
Just 29 days !!
Good morning to all
Hope everyone has an enjoyable Sunday
29 Days
16 Hours
12 Minutes
...But who's counting?
'I will live in the Past, the Present, and the Future!' Scrooge repeated, as he scrambled out of bed. 'The Spirits of all Three shall strive within me. Oh, Jacob Marley! Heaven, and the Christmas Time be praised for this! I say it on my knees, old Jacob, on my knees!' (Charles Dickens A Christmas Carol)
good afternoon everyone........
Good afternoon
hello all.................


text:
Nike Air Futurun Lightweight Running Shoe - Mens
Sorry, this item is sold out!
Looks like you've got more shoe shopping to do - have fun!
Looks like you've got more shoe shopping to do - have fun!
Item # 264615
The Nike® Air Futurun lightweight running shoe will help you master your training and performance running abilities in the blink of an eye. Made on a neutral platform for runners in need of enhanced cushioning this shoe is certain to make your future in running bright.
- Breathable mesh upper with synthetic supportive overlays
- Cushioned tongue and collar
- Dual-density Phylon midsole for responsive lightweight cushioning
- Air-Sole unit in heel
- Waffle pattern outsole
- Forefoot flex grooves for flexibility
- Imported
- View more Men's Nike Shoes
Tell us what you think!
Everyone has an opinion. Here's your chance to share yours! Be the first to write a review of this product and help your fellow shoppers pick the best of the best.


text:
Aging system draining water
Need for pipes and meters likely to raise water rates
The need for new infrastructure, including pipes and water meters, will almost certainly drive water rates up in Mancos.
"We need to do this. We don't have a choice," said Mayor Pro Tem Perry Lewis at Wednesday's board meeting.
The town is losing 20 to 30 percent its treated water after it leaves the plant because of leaky, aging pipes and water meters that aren't reading as accurately as possible.
"We're spending electricity and much needing resources and losing it somewhere along the lines, literally," said Mayor Rachel Simbeck.
The rate of the increase has yet to be determined.
The board of trustees considered the possibility of slowly phasing in higher monthly rates until they reached $41 in 2018, at the recommendation of Gabe Preston, a managing partner of RPI Consulting. These rate increases could be phased in starting at $5 in the first year and tapering off to $2.50 a year for four years. The town could also choose to raise rates by $3 a year, for five years. In 2018, the rates would be reassessed.
At the same time, Preston recommended lowering the gallons allowed per residence to 7,000 from 10,000 while increasing the overage charges from $1 to $2 per 1,000> gallons. The current monthly water rate is $25.72.
These increases would pay for the town's needed infrastructure improvements, which are estimated to cost about $3 million, according to the town's budget. These improvements range from 9,000 feet of water lines to the new water tank. In order to take out a loan to pay for improvements, the board must show the Colorado Department of Local Affairs the town has rising revenue, Preston said.
"If you were to raise it more at the beginning, it's going to give you more borrowing power," he said.
Trustee Queenie Barz said people needed to be aware that during the summer months the rate increases would amount to more than a few dollars if they used more than the allotted amount of water. She asked Preston to provide the board with estimates of how much water bills could go up based on average water use, especially during the summer. She said she wanted people to understand the increases could be substantial based on their use.
"I'm going to have sticker-shock in the summertime with my lawn if I want to keep my green lawn, but that's something I may have to think about," she said.
Preston also presented a breakdown of water rates and allotments in nearby towns. Mancos has been allotting more water at a lower rate, but it is not sustainable, Preston said.
"There is all this overhead that has to be split between a smaller number of customers," Preston said.


text:
Because the manga was way too erratic around this time. Honestly, I got a bit annoyed, so this is fine for me.
Because the manga was way too erratic around this time. Honestly, I got a bit annoyed, so this is fine for me.
I still think the episode before, ep 126 was good, when they made Itachi freaky
that Ninja with the puppet baby is the body who's arm shoots rockets or is it Sasori?
The anime is only gonna get better, next week Jiraiya infiltrates the rain village.
I love this special episode 128 for me was he best seen kushina and nagato and the other this is just to good i really like it
Kick me high, hit me low, spit on me it's gonna take more than that to break my soul.
best filler ever!!!
the next episodes will be epic!!!
Danzo is actually BERT!!!
Spoiler!Correct me if I'm wrong, but it seems to me that the "revolutionary" pupil Jirayia is trying to find amongst the ninjas, are in fact the bodies used by Pain.
I know for a fact that one with the scar on the forehead is one of the bodies of Pain, Its almost safe to assume that the rest of them are the same. Look at the pictures and judge for yourself.
Last edited by Stefano-kun; 09-24-2009 at 07:16 PM.


text:
Aerosoles At First Plush Wedge Sandal
Sorry, this item is sold out!
Looks like you've got more shoe shopping to do - have fun!
Looks like you've got more shoe shopping to do - have fun!
Item # dsw12prod4340030
Wedges are a huge trend this season and here is the perfect one to kick off your summer style! The Aerosoles At First Plush has an all natural look with a soft, comfortable footbed that is sure to keep you light on your feet.
- Faux leather upper
- Heel strap with adjustable buckle and elastic insert for easy fit
- ¾" cork platform, 3¾" covered wedge heel
- Synthetic sole
- Imported
- View more Aerosoles
By: ORogers
Location: Virginia
June 20, 2013
Good but...
"I ordered the orange and the white. They are not made the same. The white sandals have a soft foot bed. The orange ones do also but the sides of the heal bed are hard. On the white ones, the sides of the heel bed are soft. I can't do hard! They are going back."
By: ShoeAholicsUSA123
Location: Madison, WI
June 07, 2013
Great pair of wedges!
"I was looking for something cute and comfy - seems like an oxymoron, right?? But these definitely fit the bill! I wear these multiple days a week to work and I feel like they are dressy enough & still comfortable and airy (hello, summer! :))."
By: tangocat
Location: denver
May 25, 2013
Great Shoes!
"very comfy & cute...love 'em!"
By: Jennianydots
Location: Madison, WI
May 20, 2013
Love 'em!
"These shoes have everything I was looking for- they're stylish, comfortable and flattering to my wide feet. I got them in the burn orange color and I think it makes them just a bit more interesting."
Click anywhere to close this.


text:
SNS now offers Dyno Tuning !!!!!!!!!
SNS is now equipped with a 1200 whp capable Dyno Dynamics 2WD load based dyno, one of the few in this part of the country.
We can now provide our customers with custom EFI tuning with tuners who take their time with each calibration, to ensure maximum performance and safety across the entire RPM range.
At SNS we wont simpy load up a map, give 3 dyno pulls and call it a wrap....
We provide a different approach, whereas a unique calibration is created in real-time for each vehicle. We'll take as much as needed to perfect each tune. A great feature with Dyno Dynamics is that it enables us to hit each load cell, and optimize part throttle mapping, rather than just wide open throttle blasts on the typical inertia dyno that most shops utilize.
We also are availabe for outside tuner's use.
For more info call or email us!!
firstname.lastname@example.com - email
786-573-9303 - Office
SNSMOTORSPORTS.com - automotive performance parts and service - Welcome!


text:
Warren BeattyActor / Filmmaker
Born: 30 March 1937
Birthplace: Richmond, Virginia
Best known as: The star of Bonnie and Clyde and Reds
Warren Beatty began as a standard young heartthrob, making a splash opposite Natalie Wood in 1961's Splendor in the Grass. But he morphed into something more complicated, playing handsome antiheroes in complex movies like Bonnie and Clyde (1967, with Faye Dunaway), McCabe and Mrs. Miller (1971, also with Keith Carradine), and Shampoo (1975). He began writing and directing, and won an Academy Award for directing Reds, a sprawling 1981 movie about the Russian Revolution (co-starring Diane Keaton and Jack Nicholson). Beatty also earned a reputation as an off-screen heartbreaker, dating a long string of leading ladies, including Madonna, with whom he candidly appears in Truth or Dare (1991). In 1991 Beatty married actress Annette Bening, his co-star in the gangster movie Bugsy (1991, co-starring Ben Kingsley). His 1998 movie Bulworth (co-starring Halle Berry and Don Cheadle) was a political satire that seemed to echo Beatty's outspoken political views, opinions he was later to voice during a brief flirtation with a run for president in 2000.
Extra credit:
Warren Beatty and Annette Bening have four children: Kathlyn (b. 1992), Benjamin (b. 1994), Isabel (b. 1997) and Ella (b. 2000)… Beatty is the younger brother of actress Shirley MacLaine.
Copyright © 1998-2017 by Who2?, LLC. All rights reserved.


text:
Justin Bieber Fans Storm Twitter After Grammy Snub
BiebsTakesOver December 6, 2012 12:00 AM
Justin Bieber's Grammy nomination snub is causing a stir on Twitter. During the Nominations Concert there were an estimated 16,000 tweets about the teen pop sensation being shut out of the running. Here are some of the best #BieberForGrammy reaction Tweets.
Rating failed. Try again.
Request failed. Try again.
We will promote constructive and witty comments to the top, so everyone sees them!


text:
Dining Room Window Treatments
- Soft, diffused light keeps dining pleasant
- Fabric shades provide a natural, soft feel
- Wood and faux wood enhance a traditional look
- Add drapery for a luxurious setting
- Romans add a decorative touch
Presentation is an essential part of any meal and dining room window treatments can magnify the ambiance for you and your guests. Whether you are seeking a relaxed, casual look with wood blinds or cellular shades, or you lean toward a more formal dining experience, with roman shades or drapery, Blindsgalore has all styles covered. Make sure to consider the light that enters the room during different times of the day and night so that you may soften the glare and darken the space for each meal. By controlling the amount of light, you can control the mood for a romantic dinner or a happy Sunday brunch.
Good Housekeeping™ Natural Woven Shades
retail $219.40 $147.00 + an extra 20% off
Certified Best for Kids
Products with this label meet or exceed safety recommendations approved by the Window Covering Manufactures Association (WCMA) and have undergone rigorous third-party testing.
- Blackout
- Cordless
- Privacy
- Top Down/Bottom Up
- Beige / Neutral
- Brown
- Family Room / Den
- Living Room
- RV / Motorhome
- Bamboo
- Matchsticks
- Hard-to-Reach
- Eco-Friendly
- Child Safe
customer reviews for dining room
"Lovely Shade"
By Bdevine01 from Boca Raton, FL
I purchased this shade for my oversized living room window. It was simple to install and is very well made. It is easy to open and close and looks great.View this product


text:
Serve this stew topped with shredded Mexican cheese blend and chopped fresh cilantro leaves for an extra-special touch.
Frozen small whole onions, also called pearl onions, are loaded with flavor and are so convenient to use. If you don't have them on hand, you can substitute 1/2 cup chopped onion.


text: Well Lucy pulled one out of her butt this time, Im impressed I just hope it isn't a short lived powerup. And the Spirit King keeps getting more and more boss, it seems like Mard Geer and him have a past together, maybe all the higher ups know the spirit king too? Would like to know his story. And It looks like the typical match up for a FT fight, fire/fire, ice/ice, blade/metal, and whatever/whatever grrrr


text:
Santoni Pebbled Leather Oxford
Sorry, this item is sold out!
Looks like you've got more shoe shopping to do - have fun!
Looks like you've got more shoe shopping to do - have fun!
Item # 262809
A passion for extreme quality and innovation is central to every Santoni style. Their attention to detail has never wavered over the years and this pebbled leather driving oxford is sure to become a staple in your shoe collection.
- Pebbled leather upper
- Lace-up
- Tapered round toe
- Fully lined in leather
- Leather insole
- Leather and rubber pod sole
- Rubber heel guard prevents wear and tear while driving
- Made in Italy
- Online Exclusive!
By: JeremyW
Location: Arlington, VA
May 30, 2013
"Very comfortable and the leather is very soft."
Click anywhere to close this.


text:
404 File Not Found
Host by NetBox Version 2.8 Build 4128
Alterna Caviar Repair RX Instant Recovery Conditioner-8.5 oz.
A restorative, paraben-free conditioner that transforms severely damaged hair, intensely nourishing & repairing each individual strand.
A deeply reparative conditioner formulated with Strand-Building Proteins, which reconstruct each individual strand of hair from the inside out to rebuild, resurface and restore hair, leaving strands strong, healthy, smooth, shiny & fully restored.
Key product benefits are derived from Strand-Building Proteins, which target damage at the microscopic level, working to repair each individual strand of hair:
REBUILDS: This unique ingredient blend delivers essential nutrients to the hair's interior cortex, nourishing to help strengthen strands. Fills in gaps & tears in the damaged cuticle, reconstructing this protective layer to ensure that nutrients do not escape. Cements the newly constructed, exterior cuticle to the interior cortex, ensuring that the scales of the hair lay flat.
RESURFACES: Seals and reinforces the cuticle layer with a defensive shield that strengthens the strand to increase resistance to breakage while infusing hair with vital antioxidants to help prevent free radical penetration and other damage from occurring.
RESTORES: Leaves strands fully restored to their healthy, pre-damaged state. Hair is stronger, smoother, softer and shinier.
Color Hold: A proprietary color protection complex found in all Alterna products that provides the highest level of color protection from color f
Product Notes
List: $32.00
|Unit Price
|Instant Recovery Conditioner
Please choose which cart you want to add the item.
By choosing one of the above, you are able to shop for both yourself and a registrant at the same time. Once you are ready to checkout your items will be waiting for you in both your personal and registry shopping carts.
Still need assistance?
Please contact us at (1-888-696-0423)


text:
Main Content
This item ships within one business day.
$4.99 flat rate shipping. See other shipping options.
- 65% Polyester/35% Cotton lining
- 98% Cotton/2% Lycra shell
- Quality embroidery
- Two back pockets
- Two front pockets
- Waist button closure with zipper fly
- Custom metal accents
- Imported
- Imported
- Brand: Fox
Special event items are produced by manufacturers only after the outcome of a game or event. These are advanced sale items and will ship immediately after they are received in our warehouse.
Manufacturer direct items are shipped directly from the manufacturer. These items are not available for international or expedited shipping.
Customized items can be personalized with options such as your name, your favorite number, and/or designs. Some options may be limited by league rules.